Bioequivalence Study of Sulfadoxine/Pyrimethamine 500/25 mg Dispersible Tablet

NCT06522763 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Fasting

Interventions

DRUG: Sulfadoxine 500 MG / Pyrimethamine 25 MG dispersible tablets.
DRUG: Sulfadoxine 500 MG / Pyrimethamine 25 MG dispersible tablets in SPAQ

Sponsor

Swiss Pharma Nigeria Limited

Collaborators

[object Object]